Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News The ultimate guide to removing blackheads naturally Blackheads are a widespread skin concern caused by clogged pores filled with oil, dead skin cells, and bacteria.… bypharmanewsdailyJanuary 18, 2025